Press Releases
Latest
ProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023
Presentation Details: Title: Differentiation of PMN310 from Other Amyloid-Beta-Directed Antibodies: Ability to Selectively Target Toxic Brain Oligomers Despite…